back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-07-08 16:43 Tx date 2021-07-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,814
-3,646 vol $9.00 each |
0 | |
| Filed 2021-07-08 16:42 Tx date 2021-07-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,385
+3,646 vol $0.38 each |
3,646 | |
| Filed 2021-07-08 16:40 Tx date 2021-07-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,385.48
-3,646 vol $0.38 each |
81,427 | |
| Filed 2021-06-08 17:49 Tx date 2021-06-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,152.42
-3,646 vol $8.27 each |
0 | |
| Filed 2021-06-08 17:48 Tx date 2021-06-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,385
+3,646 vol $0.38 each |
3,646 | |
| Filed 2021-06-08 17:45 Tx date 2021-06-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,385.48
-3,646 vol $0.38 each |
85,073 | |
| Filed 2021-05-10 17:20 Tx date 2021-05-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,907.80
-3,646 vol $9.30 each |
0 | |
| Filed 2021-05-10 17:19 Tx date 2021-05-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,385
+3,646 vol $0.38 each |
3,646 | |
| Filed 2021-05-10 17:17 Tx date 2021-05-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,385.48
-3,646 vol $0.38 each |
88,719 | |
| Filed 2021-04-09 17:11 Tx date 2021-04-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,449.72
-3,646 vol $10.82 each |
0 | |
| Filed 2021-04-09 17:10 Tx date 2021-04-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,385
+3,646 vol $0.38 each |
3,646 | |
| Filed 2021-04-09 17:09 Tx date 2021-04-07 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,385.48
-3,646 vol $0.38 each |
92,365 | |
| Filed 2021-03-15 14:36 Tx date 2021-03-12 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-34,916.49
-2,917 vol $11.97 each |
0 | |
| Filed 2021-03-15 14:34 Tx date 2021-03-12 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$12,338
+2,917 vol $4.23 each |
2,917 | |
| Filed 2021-03-15 14:31 Tx date 2021-03-12 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-12,338.91
-2,917 vol $4.23 each |
96,011 | |
| Filed 2021-03-10 13:47 Tx date 2021-03-08 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,861.06
-3,646 vol $10.11 each |
0 | |
| Filed 2021-03-10 13:47 Tx date 2021-03-08 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,385
+3,646 vol $0.38 each |
3,646 | |
| Filed 2021-03-10 13:44 Tx date 2021-03-08 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,385.48
-3,646 vol $0.38 each |
98,928 | |
| Filed 2021-02-10 20:38 Tx date 2021-02-09 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,248.416
-584 vol $14.12 each |
0 | |
| Filed 2021-02-10 20:37 Tx date 2021-02-09 |
$TRIL
Trillium Therapeutics Inc. |
Uger, Robert
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$7,136
+584 vol $12.22 each |
584 |